<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
                    <title>Rheumatology</title>
            <link>https://medicalxpress.com/rheumatology-news/</link>
            <language>en-us</language> 
            <description>Latest medical news and research in Rheumatology</description>

                            <item>
                    <title>First potential probiotic treatment for lupus identified by researchers</title>
                    <description>Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, have found a link between a bacterium in the gut microbiome (ecosystem) and lupus that could lead to more effective treatment of the disease, described in a study published in Nature Communications.</description>
                    <link>https://medicalxpress.com/news/2026-06-potential-probiotic-treatment-lupus.html</link>
                    <category></category>
                    <pubDate>Thu, 25 Jun 2026 18:00:03 EDT</pubDate>
                    <guid isPermaLink="false">news701626442</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2020/probiotics.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Immune cell–fibroblast crosstalk may be the key trigger of autoimmune diseases</title>
                    <description>In autoimmune disorders, immune cells targeting &quot;self&quot; proteins are mistakenly activated, resulting in abnormal expansion and responsiveness. These disorders are known to reduce patients&#039; quality of life over a prolonged period. This can be attributed to CD4+ T cells, which play a key role in inducing persistent inflammation, recruiting other immune cells, including antibody-producing B cells, and inflicting tissue damage.</description>
                    <link>https://medicalxpress.com/news/2026-06-immune-cellfibroblast-crosstalk-key-trigger.html</link>
                    <category></category>
                    <pubDate>Wed, 24 Jun 2026 18:40:02 EDT</pubDate>
                    <guid isPermaLink="false">news701536083</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/immune-cellfibroblast.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Hidden mechanism driving joint tissue growth in rheumatoid arthritis has been found</title>
                    <description>Researchers at Hospital for Special Surgery (HSS) have identified a specialized population of immune cells that plays a central role in driving abnormal tissue growth in rheumatoid arthritis (RA), offering new insight into disease progression and potential treatment strategies. The study, published in Science Translational Medicine, reveals that a subset of immune cells known as SPP1ʰⁱ macrophages works in tandem with structural cells and protein scaffolds to promote excessive tissue expansion in the joints of patients with RA.</description>
                    <link>https://medicalxpress.com/news/2026-06-hidden-mechanism-joint-tissue-growth.html</link>
                    <category></category>
                    <pubDate>Wed, 24 Jun 2026 15:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news701531835</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/hss-researchers-identi.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Ultrasound-based approach may reduce harmful inflammation and support joint healing</title>
                    <description>As an aging population experiences joint pain and inflammation at an all-time high, researchers at The University of Alabama in Huntsville (UAH), a part of The University of Alabama System, have published new findings suggesting continuous low-intensity ultrasound may help shift the body&#039;s immune response from prolonged inflammation toward tissue repair, a discovery that could eventually contribute to novel treatments for joint injuries and post-traumatic osteoarthritis.</description>
                    <link>https://medicalxpress.com/news/2026-06-ultrasound-based-approach-inflammation-joint.html</link>
                    <category></category>
                    <pubDate>Fri, 19 Jun 2026 10:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news701081161</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/joint-pain.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>CAR T-cell therapy shows early promise in severe lupus</title>
                    <description>Early results from a UCL- and UCLH-led clinical trial suggest that a type of CAR T-cell therapy—developed by Autolus Therapeutics, a UCL spinout—could offer a new treatment approach for people with severe, treatment-resistant lupus. The findings, presented at the EULAR European Congress of Rheumatology (EULAR 2026), come from the ongoing Phase I CARLYSLE study, which is evaluating obecabtagene autoleucel (obe-cel) in patients with severe refractory systemic lupus erythematosus (SLE). The early data indicate that the therapy has a favorable safety profile and may lead to meaningful improvements in disease activity.</description>
                    <link>https://medicalxpress.com/news/2026-06-car-cell-therapy-early-severe.html</link>
                    <category></category>
                    <pubDate>Mon, 15 Jun 2026 17:20:06 EDT</pubDate>
                    <guid isPermaLink="false">news700739769</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/car-t-cell-therapy-sho-1.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Scientists reveal an autoimmune vicious cycle in Sjögren&#039;s disease</title>
                    <description>Sjögren&#039;s disease is a widespread chronic autoimmune disorder that attacks the body&#039;s own glands, yet its underlying disease mechanisms remain poorly understood. In a recent study, researchers from Japan discovered a self-reinforcing loop between different immune cells that sustains autoimmune responses in patients with Sjögren&#039;s disease. Their findings pave the way for safer and more effective therapies.</description>
                    <link>https://medicalxpress.com/news/2026-06-scientists-reveal-autoimmune-vicious-sjgren.html</link>
                    <category></category>
                    <pubDate>Thu, 11 Jun 2026 09:00:04 EDT</pubDate>
                    <guid isPermaLink="false">news700386541</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/scientists-reveal-an-a.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Drug reduces the risk of developing rheumatoid arthritis, clinical trial finds</title>
                    <description>A clinical trial led by researchers from Hospital Clínic de Barcelona, the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and the Institute of Advanced Chemistry of Catalonia (IQAC-CSIC) compared the effectiveness of abatacept and hydroxychloroquine in preventing the development of rheumatoid arthritis in patients with palindromic rheumatism, an autoimmune disease that progresses to arthritis in approximately half of all patients.</description>
                    <link>https://medicalxpress.com/news/2026-06-drug-rheumatoid-arthritis-clinical-trial.html</link>
                    <category></category>
                    <pubDate>Wed, 10 Jun 2026 17:20:04 EDT</pubDate>
                    <guid isPermaLink="false">news700323722</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/arthritis.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Common arthritis drugs reduce systemic Sjögren&#039;s disease activity in 24 weeks</title>
                    <description>A combination of two widely available anti-rheumatic drugs offers the first effective and affordable treatment for patients with Sjögren&#039;s disease with systemic disease activity, according to new results from a clinical trial coordinated by UMC Utrecht. The study showed that treatment with leflunomide and hydroxychloroquine reduced disease activity in patients with moderate-to-severe disease while maintaining a favorable safety profile.</description>
                    <link>https://medicalxpress.com/news/2026-06-common-arthritis-drugs-sjgren-disease.html</link>
                    <category></category>
                    <pubDate>Sat, 06 Jun 2026 15:40:03 EDT</pubDate>
                    <guid isPermaLink="false">news699978269</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/widely-available-drug.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New drug cuts relapse risk by half in rare immune disorder trial</title>
                    <description>Stanford Medicine researchers and their colleagues found that a new drug, obexelimab, significantly reduces the risk of relapse in patients with IgG4-related disease, a rare chronic immune condition often misdiagnosed as cancer.</description>
                    <link>https://medicalxpress.com/news/2026-06-drug-relapse-rare-immune-disorder.html</link>
                    <category></category>
                    <pubDate>Thu, 04 Jun 2026 15:20:07 EDT</pubDate>
                    <guid isPermaLink="false">news699803308</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/new-drug-cuts-relapse.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>New RNA sequencing method reveals hidden layer of immune system control</title>
                    <description>Researchers at University Medical Center Utrecht have uncovered a previously underappreciated mechanism that helps immune cells to respond rapidly to infections. Using advanced long-read RNA sequencing, the team shows that alternative RNA splicing, which means how genes are edited into different messenger RNA variants, plays a central role in shaping immune responses. The findings provide new insights into immune-mediated diseases (such as infections, rheumatoid arthritis and lupus) and may open the door to more targeted therapies.</description>
                    <link>https://medicalxpress.com/news/2026-06-rna-sequencing-method-reveals-hidden.html</link>
                    <category></category>
                    <pubDate>Tue, 02 Jun 2026 18:40:03 EDT</pubDate>
                    <guid isPermaLink="false">news699636061</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2017/rna.png" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Largest study of knee osteoarthritis tissue reveals core biological pathways underlying the disease</title>
                    <description>A major international study led by researchers at the Kennedy Institute of Rheumatology at the University of Oxford has found that osteoarthritis (OA)—the most common form of arthritis worldwide—is not a collection of separate diseases, as many scientists had previously speculated, but rather a single condition with common core underlying biological pathways.</description>
                    <link>https://medicalxpress.com/news/2026-06-largest-knee-osteoarthritis-tissue-reveals.html</link>
                    <category></category>
                    <pubDate>Tue, 02 Jun 2026 15:20:02 EDT</pubDate>
                    <guid isPermaLink="false">news699623101</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/knee-injection.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Why some chikungunya virus infections may turn chronic</title>
                    <description>Chikungunya virus, which is transmitted to people by infected Aedes mosquitoes and characterized by high fever and intense joint swelling and pain, has made a resurgence in many countries around the world in recent years.</description>
                    <link>https://medicalxpress.com/news/2026-05-chikungunya-virus-infections-chronic.html</link>
                    <category></category>
                    <pubDate>Sat, 30 May 2026 16:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news699190591</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/aedes-aegypti.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Depression may not only be a consequence, but also a cause of rheumatoid arthritis</title>
                    <description>According to researchers at Semmelweis University, not only inflammation, but also sleep disorders, depression, obesity, and smoking may sustain persistent rheumatic symptoms. In their publications in the journals Nature Reviews Rheumatology and The Lancet Rheumatology, they also proposed a model that can help identify and treat the true causes of symptoms in time.</description>
                    <link>https://medicalxpress.com/news/2026-05-depression-consequence-rheumatoid-arthritis.html</link>
                    <category></category>
                    <pubDate>Thu, 28 May 2026 10:40:06 EDT</pubDate>
                    <guid isPermaLink="false">news699180361</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2025/older-depressed.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>CAR T moves beyond cancer, targeting autoimmune disease with immune system reset</title>
                    <description>At age 49, Jan Janisch-Hanzlik&#039;s multiple sclerosis was destroying her freedom to live the life she wanted. She gave up her active nursing job for a desk role. Frequent falls made her afraid to carry her grandchildren. She had to move to a bigger house to make room for the wheelchair she feared she might end up needing full-time.</description>
                    <link>https://medicalxpress.com/news/2026-05-car-cancer-autoimmune-disease-immune.html</link>
                    <category></category>
                    <pubDate>Tue, 26 May 2026 11:40:01 EDT</pubDate>
                    <guid isPermaLink="false">news699012782</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/a-revolutionary-cancer.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Blood protein study of 78,000 people uncovers disease mechanisms and drug repurposing leads</title>
                    <description>Involving a collaboration with 118 investigators contributing from 89 institutions, scientists from Queen Mary University of London&#039;s Precision Healthcare University Research Institute and Berlin Institute of Health (BIH) at Charité have led the world&#039;s largest study on the genetic regulation of blood proteins.</description>
                    <link>https://medicalxpress.com/news/2026-05-blood-protein-people-uncovers-disease.html</link>
                    <category></category>
                    <pubDate>Wed, 06 May 2026 15:20:27 EDT</pubDate>
                    <guid isPermaLink="false">news697289341</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/largest-study-on-genet.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>How bones make marrow: Newly identified &#039;organizer&#039; cells also reappear after fractures</title>
                    <description>Bone marrow is the spongy tissue located within the hollow center of bones, serving as the primary site for the continuous production of red blood cells, platelets, and white blood cells. Despite its physiological importance, the developmental mechanism by which this soft tissue is formed within the rigid confines of hard bone has remained largely unknown.</description>
                    <link>https://medicalxpress.com/news/2026-04-bones-marrow-newly-cells-reappear.html</link>
                    <category></category>
                    <pubDate>Tue, 28 Apr 2026 17:30:01 EDT</pubDate>
                    <guid isPermaLink="false">news696614941</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/researchers-identify-t-3.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>T cells, not B cells, are the culprit in kidney damage in lupus, study shows</title>
                    <description>Kidney damage is a serious complication affecting individuals with lupus, an autoimmune disease where immune B cells malfunction and produce antibodies that attack the body&#039;s own cells, tissues, and organs.</description>
                    <link>https://medicalxpress.com/news/2026-04-cells-culprit-kidney-lupus.html</link>
                    <category></category>
                    <pubDate>Tue, 28 Apr 2026 09:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news696585602</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/t-cells-not-b-cells-ar.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>Common drug fails to ease knee osteoarthritis pain in largest trial yet</title>
                    <description>The University of Tasmania&#039;s Menzies Institute for Medical Research has found that the commonly prescribed medication, Diacerein, does not improve knee osteoarthritis symptoms, following a national study. Diacerein, a medication derived from plants such as rhubarb and aloe vera, has long been recognized for its anti-inflammatory properties and is commonly used to treat osteoarthritis in Europe and Asia.</description>
                    <link>https://medicalxpress.com/news/2026-04-common-drug-ease-knee-osteoarthritis.html</link>
                    <category></category>
                    <pubDate>Tue, 21 Apr 2026 19:20:01 EDT</pubDate>
                    <guid isPermaLink="false">news696004081</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2018/1-osteoarthrit.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>GLP-1 in joint fluid may let weight-loss drugs target arthritis directly</title>
                    <description>Arthritis includes a range of conditions that affect the joints, from inflammatory diseases such as rheumatoid arthritis and psoriatic arthritis to more common conditions like osteoarthritis. Many people experience pain, stiffness, and a reduced quality of life. Treatment today focuses on reducing inflammation and relieving symptoms, depending on the type of arthritis. However, researchers from the Department of Biomedicine at Aarhus University have now identified a new possible route for future treatments. Their research is published in The Lancet Rheumatology journal.</description>
                    <link>https://medicalxpress.com/news/2026-04-glp-joint-fluid-weight-loss.html</link>
                    <category></category>
                    <pubDate>Thu, 16 Apr 2026 16:00:05 EDT</pubDate>
                    <guid isPermaLink="false">news695569381</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/arthritis.jpg" width="90" height="90" />
                                    </item>
                            <item>
                    <title>PEPITEM &#039;replacement therapy&#039; shows potential for early-stage inflammatory arthritis</title>
                    <description>Scientists investigating the naturally occurring immunopeptide PEPITEM have shown reductions in arthritic joint swelling to a degree comparable to the current standard of care, and reduce the inflammatory changes that cause joint damage.</description>
                    <link>https://medicalxpress.com/news/2026-04-pepitem-therapy-potential-early-stage.html</link>
                    <category></category>
                    <pubDate>Mon, 13 Apr 2026 04:00:02 EDT</pubDate>
                    <guid isPermaLink="false">news695035561</guid>
                                            <media:thumbnail url="https://scx1.b-cdn.net/csz/news/tmb/2026/wrist-pain.jpg" width="90" height="90" />
                                    </item>
                    </channel>
</rss>
